Complementary Acupuncture in Parkinson's Disease: A Spect Study

REFERENCES

• Alavi, A., Newberg, A. B., Souder, E., & Berlin, J. A. (1993). Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute brain metabolism as reliable discriminations. Journal of Nuclear Medicine, 34(10), 1681–1687.
   PubMedGoogle Scholar
• Booij, J., & Knol, R. J. J. (2007). SPECT imaging of the dopamine system in (premotor) Parkinson's disease. Parkinsonism and Related Disorders, 13, 425–428.
   PubMedGoogle Scholar
• Cheesman, A. L., Barker, R. A., Lewis, S. J., Robbins, T. W., Owen, A. M., & Brooks, D. J. (2005). Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 76(9), 1204–1210.
   PubMed Web of Science ®Google Scholar
• Cristian, A., Katz, M., Cutrone, E., & Walker, R. H. (2005). Evaluation of acupuncture in the treatment of Parkinson's disease: A double-blind pilot study. Movement Disorders, 20(9), 1185–1188.
   PubMed Web of Science ®Google Scholar
• Eng, M. L., Lyons, K. E., Greene, M. S., & Pahwa, R. (2006). Open-label trial regarding the use of acupuncture and yin tui na in Parkinson's disease outpatients: A pilot study on efficacy, tolerability, and quality of life. Journal of Alternative and Complementary Medicine, 12(4), 395–399.
   PubMed Web of Science ®Google Scholar
• Gao, G. D. (2004). The Diagnosis and Treatment Keys for Parkinson's Disease. Nanjing, China: Jiangsu Science and Technology Press.
   Google Scholar
• Hesse, S., Oehlwein, C., Barthel, H., Schwarz, J., Polster, D., Wagner, A., (2006). Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. Journal of Neural Transmission, 113(9), 1177–1190.
   PubMedGoogle Scholar
• Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism-onset progression and mortality. Neurology, 17(5), 427–437.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Chen, J., Htut, W. M., Lai, X. S., & Wik, G. (2007). Acupuncture increases cerebral glucose metabolism in human vascular dementia. International Journal of Neuroscience, 117(7), 1029–1037.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Jiang, X. M., Zhuo, Y., Tang, A. W., & Wik, G. (2009). Complementary acupuncture treatment increases cerebral metabolism in patients with Parkinson's disease. International Journal of Neuroscience, 119(8), 1190–1197.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Lai, X., Zeng, T., Tang, C., Yang, J., Wik, G., Cerebral effects of Waiguan (TE5) acupuncture and touch: An fMRI study. Submitted for publication, International Journal of Neuroscience.
   Google Scholar
• Huang, W. S., Lin, S. Z., Lin, J. C., Wey, S. P., Ting, G., & Liu, R. S. (2001). Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. Journal of Nuclear Medicine, 42(9), 1303–1308.
   PubMedGoogle Scholar
• Hyun, I. Y., Lee, J. S., Rha, J. H., Lee, I. K., Ha, C. K., & Lee, D. S. (2001). Different uptake of Tc-99m-ECD and Tc-99m-HMPAO in the same brains: Analysis by statistical parametric mapping. European Journal of Nuclear Medicine, 28(2), 191–197.
   Google Scholar
• Jiang, X. M., Huang, Y., Zhuo, Y., & Gao, Y. P. (2006). Therapeutic effects of scalp electroacupuncture in Parkinson's disease. ACTA Southern Medical University, 26(1), 114–116.
   Google Scholar
• Kim, Y. M., Lim, H. H., Song, Y. K., Lee, H. H., Lim, S., Han, S. M., . (2005). Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neuroscience Letters, 384(1/2), 133–138.
   PubMedGoogle Scholar
• Korak, L. E., Kayes, L., McCarty, R., Walkinshaw, C., Congdon, S., Kleinberger, J., (2008). Use of complementary and alternative medicine (CAM) by Washington State hospices. American Journal of Hospice & Palliative Medicine, 25(6), 463–468.
   PubMedGoogle Scholar
• Kung, H. F. (2001). Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Nuclear Medicine and Biology, 28(5), 505–508.
   PubMedGoogle Scholar
• Kung, H. F., Kung, M. P., Wey, S. P., Lin, K. J., & Yen, T. C. (2007). Clinical acceptance of a molecular imaging agent: A long march with Tc-99mTRODAT. Nuclear Medicine and Biology, 34(7), 787–789.
   PubMedGoogle Scholar
• Lang, A. E., & Lozano, A. M.. (1998). Parkinson's disease: First of two parts. New England Journal of Medicine, 339(15), 1044–1053.
   PubMed Web of Science ®Google Scholar
• Liang, X. B., Liu, X. Y., Li, F. Q., Luo, Y., Lu, J., Zhang, W. M., (2002). Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Molecular Brain Research, 108(1/2), 51–59.
   PubMedGoogle Scholar
• Liu, X. Y., Zhou, H. F., Pan, Y. L., Liang, X. B., Niu, D. B., Xue, B., (2004). Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats. Experimental Neurology, 189(1), 189–196.
   PubMedGoogle Scholar
• Nurmi, E., Ruottinen, H. M., Kaasinen, V., Bergman, J., Haaparanta, M., Solin, O., . (2000). Progressive in Parkinson's disease: A positron emission tomography study with a dopamine transport ligand 18F-CFT. Annals of Neurology, 47(6), 804–808.
   PubMedGoogle Scholar
• Ouchi, Y., Yoshikawa, E., Okada, H., Futatsubashi, M., Sekine, Y., Iyo, M., . (1999). Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography. Annals of Neurology, 45(5), 601–610.
   PubMedGoogle Scholar
• Quinn, N., Brown, R., Craufurd, D., Goldman, S., Hodges, J., Kieburtz, K., . (1996). Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD). Movement Disorders, 11(2), 143–150.
   PubMedGoogle Scholar
• Rabinstein, A. A., & Shulman, L. M. (2003). Acupuncture in clinical neurology. Neurologist, 9(3), 137–148.
   PubMedGoogle Scholar
• Rinne, J. O., Portin, R., Ruottinen, H., Nurmi, E., Bergman, J., Haaparanta, M., . (2000). Cognitive impairment and the brain dopaminergic system in Parkinson disease—18F-fluorodopa positron emission tomographic study. Archives of Neurology, 57(4), 470–475.
   PubMed Web of Science ®Google Scholar
• Tan, L. C., Lau, P. N., Jamora, R. D., & Chan, E. S. (2006). Use of complementary therapies in patients with Parkinson's disease in Singapore. Movement Disorders, 21(1), 86–89.
   PubMedGoogle Scholar
• Varrone, A., Sansone, V., Pellecchia, M. T., Amboni, M., Salvatore, E., De Michele, G., (2008). Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with 123I-FP-CIT. European Journal of Nuclear Medicine and Molecular Imaging, 35(7), 1343–1349.
   PubMedGoogle Scholar